BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15227532)

  • 1. A short synthesis of (+/-)-cytisine.
    Botuha C; Galley CM; Gallagher T
    Org Biomol Chem; 2004 Jul; 2(13):1825-6. PubMed ID: 15227532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses of (+)-cytisine, (-)-kuraramine, (-)-isokuraramine, and (-)-jussiaeiine A.
    Honda T; Takahashi R; Namiki H
    J Org Chem; 2005 Jan; 70(2):499-504. PubMed ID: 15651792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of (+)-sparteine-like diamines for asymmetric synthesis.
    Dearden MJ; McGrath MJ; O'Brien P
    J Org Chem; 2004 Aug; 69(17):5789-92. PubMed ID: 15307761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flexible strategy for the synthesis of tri- and tetracyclic lupin alkaloids: synthesis of (+)-cytisine, (+/-)-anagyrine, and (+/-)-thermopsine.
    Gray D; Gallagher T
    Angew Chem Int Ed Engl; 2006 Apr; 45(15):2419-23. PubMed ID: 16521145
    [No Abstract]   [Full Text] [Related]  

  • 5. Concise synthesis of (+/-)-cytisine via lithiation of N-Boc-bispidine.
    Stead D; O'Brien P; Sanderson AJ
    Org Lett; 2005 Sep; 7(20):4459-62. PubMed ID: 16178558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core modification of cytisine: a modular synthesis.
    Hirschhäuser C; Haseler CA; Gallagher T
    Angew Chem Int Ed Engl; 2011 May; 50(22):5162-5. PubMed ID: 21520366
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies toward labeling cytisine with [11C]phosgene: rapid synthesis of a delta-lactam involving a new chemoselective lithiation-annulation method.
    Rouden J; Seitz T; Lemoucheux L; Lasne MC
    J Org Chem; 2004 May; 69(11):3787-93. PubMed ID: 15153010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First total synthesis of (+/-)-3-hydroxy-11-norcytisine: structure confirmation and biological characterization.
    Yohannes D; Hansen CP; Akireddy SR; Hauser TA; Kiser MN; Gurnon NJ; Day CS; Bhatti B; Caldwell WS
    Org Lett; 2008 Dec; 10(23):5353-6. PubMed ID: 19007172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances on the Bioactivities, Total Synthesis, Structural Modification, and Structure-Activity Relationships of Cytisine Derivatives.
    Huang X; Xu H
    Mini Rev Med Chem; 2020; 20(5):369-395. PubMed ID: 31686638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
    Chellappan SK; Xiao Y; Tueckmantel W; Kellar KJ; Kozikowski AP
    J Med Chem; 2006 May; 49(9):2673-6. PubMed ID: 16640326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aza-Michael reaction of 12-N-carboxamide of (-)-cytisine under high pressure conditions.
    Tsypysheva IP; Lobov AN; Kovalskaya AV; Petrova PR; Ivanov SP; Rameev SA; Borisevich SS; Safiullin RL; Yunusov MS
    Nat Prod Res; 2015; 29(2):141-8. PubMed ID: 25330752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.
    Pérez EG; Méndez-Gálvez C; Cassels BK
    Nat Prod Rep; 2012 May; 29(5):555-67. PubMed ID: 22367109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total enantioselective synthesis of (-)-cytisine.
    Danieli B; Lesma G; Passarella D; Sacchetti A; Silvani A; Virdis A
    Org Lett; 2004 Feb; 6(4):493-6. PubMed ID: 14961606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of bisalkaloid derivatives of dicarboxylic acids based on lupinine, anabasine and cytisine as cholinesterase inhibitors of various origin].
    Rozengart EV; Basova NE
    Zh Evol Biokhim Fiziol; 2004; 40(4):305-10. PubMed ID: 15481367
    [No Abstract]   [Full Text] [Related]  

  • 15. (-)-Cytisine and derivatives: synthesis, reactivity, and applications.
    Rouden J; Lasne MC; Blanchet J; Baudoux J
    Chem Rev; 2014 Jan; 114(1):712-78. PubMed ID: 24117010
    [No Abstract]   [Full Text] [Related]  

  • 16. Short access to (+)-lupinine and (+)-epiquinamide via double hydroformylation.
    Airiau E; Spangenberg T; Girard N; Breit B; Mann A
    Org Lett; 2010 Feb; 12(3):528-31. PubMed ID: 20038131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic instinct: design, synthesis and evaluation of (+)-sparteine surrogates for asymmetric synthesis.
    O'Brien P
    Chem Commun (Camb); 2008 Feb; (6):655-67. PubMed ID: 18478687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of (+)-epiquinamide.
    Wijdeven MA; Botman PN; Wijtmans R; Schoemaker HE; Rutjes FP; Blaauw RH
    Org Lett; 2005 Sep; 7(18):4005-7. PubMed ID: 16119953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconstructing cytisine: The syntheses of (+/-)-cyfusine and (+/-)-cyclopropylcyfusine, fused ring analogs of cytisine.
    Yohannes D; Procko K; Lebel LA; Fox CB; O'Neill BT
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2316-9. PubMed ID: 18356044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors.
    Rozengart EV
    Dokl Biochem Biophys; 2003; 388():39-42. PubMed ID: 12741131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.